Icenticaftor, Novel Therapy for COPD: This Glass Is Half Full

Am J Respir Crit Care Med. 2023 Aug 15;208(4):346-348. doi: 10.1164/rccm.202307-1175ED.

Author

Stephen I Rennard¹

Affiliation

¹ Department of Internal Medicine University of Nebraska Medical Center Omaha, Nebraska.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cystic Fibrosis Transmembrane Conductance Regulator*
Double-Blind Method
Humans
Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

Cystic Fibrosis Transmembrane Conductance Regulator
icenticaftor
CFTR protein, human